79 related articles for article (PubMed ID: 10426570)
1. Inverse distribution of serum sodium and potassium in uncontrolled inpatients with diabetes mellitus.
Saito T; Ishikawa S; Higashiyama M; Nakamura T; Rokkaku K; Hayashi H; Kusaka I; Nagasaka S; Saito T
Endocr J; 1999 Feb; 46(1):75-80. PubMed ID: 10426570
[TBL] [Abstract][Full Text] [Related]
2. Correlation between serum electrolytes and fasting glucose and Hb1Ac in Saudi diabetic patients.
Al-Rubeaan K; Siddiqui K; Abu Risheh K; Hamsirani R; Alzekri A; Alaseem A; Saleh SM; Al-Yami Z; Al-Ghamdi A; Alayed K
Biol Trace Elem Res; 2011 Dec; 144(1-3):463-8. PubMed ID: 21818670
[TBL] [Abstract][Full Text] [Related]
3. Day-to-day variation in glycemic control in type I and type II diabetes mellitus.
Bantle JP; Laine DC
Diabetes Res; 1988 Jul; 8(3):147-9. PubMed ID: 3229076
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor in hypertensive and normotensive diabetic patients.
Ferri C; Piccoli A; Laurenti O; Bellini C; De Mattia G; Santucci A; Balsano F
Diabetes Care; 1994 Mar; 17(3):195-200. PubMed ID: 8174447
[TBL] [Abstract][Full Text] [Related]
5. Electrolytes and NA(+)-K(+)-ATPase: potential risk factors for the development of diabetic nephropathy.
Shahid SM; Mahboob T
Pak J Pharm Sci; 2008 Apr; 21(2):172-9. PubMed ID: 18390448
[TBL] [Abstract][Full Text] [Related]
6. Increasing serum osteocalcin after glycemic control in diabetic men.
Sayinalp S; Gedik O; Koray Z
Calcif Tissue Int; 1995 Dec; 57(6):422-5. PubMed ID: 8581873
[TBL] [Abstract][Full Text] [Related]
7. Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.
Gjessing HJ; Matzen LE; Faber OK; Frøland A
Diabetologia; 1989 May; 32(5):305-11. PubMed ID: 2666217
[TBL] [Abstract][Full Text] [Related]
8. A study of serum free C-peptide responses to oral glucose load in diabetic patients: with special reference to types of diabetes and methods of treatment.
Hsieh SD; Akanuma Y; Takaku F
Tohoku J Exp Med; 1984 Mar; 142(3):249-60. PubMed ID: 6374968
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell electrolyte changes in patients with juvenile diabetes mellitus.
Román F; Toldi Z; Kürti K; Pataki L
Acta Paediatr Hung; 1990; 30(2):233-9. PubMed ID: 2248802
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
[TBL] [Abstract][Full Text] [Related]
11. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
[TBL] [Abstract][Full Text] [Related]
12. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
Ubukata E
Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
[TBL] [Abstract][Full Text] [Related]
13. Serum electrolytes and osmolality in diabetes mellitus.
Rao GM
Indian J Med Sci; 1992 Oct; 46(10):301-3. PubMed ID: 1293047
[TBL] [Abstract][Full Text] [Related]
14. Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma.
Finotti P; Palatini P
Diabetologia; 1986 Sep; 29(9):623-8. PubMed ID: 3025045
[TBL] [Abstract][Full Text] [Related]
15. C-peptide immunoreactivity and insulin content in the diabetic human pancreas and the relation to the stability of diabetic serum glucose level.
Tasaka Y; Marumo K; Inoue Y; Hirata Y
Acta Endocrinol (Copenh); 1986 Nov; 113(3):355-62. PubMed ID: 3538738
[TBL] [Abstract][Full Text] [Related]
16. Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients.
Goto A; Takaichi M; Kishimoto M; Takahashi Y; Kajio H; Shimbo T; Noda M
Endocr J; 2010; 57(3):237-44. PubMed ID: 20032566
[TBL] [Abstract][Full Text] [Related]
17. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
[TBL] [Abstract][Full Text] [Related]
18. Effect of glucose/insulin infusion and magnesium supplementation on serum and muscle sodium and potassium and muscle [3H]ouabain binding capacity in Type 1 diabetes mellitus.
Djurhuus MS; Klitgaard NA; Pedersen KK
Scand J Clin Lab Invest; 2003; 63(2):93-102. PubMed ID: 12751690
[TBL] [Abstract][Full Text] [Related]
19. Fasting C-peptide and Related Parameters Characterizing Insulin Secretory Capacity for Correctly Classifying Diabetes Type and for Predicting Insulin Requirement in Patients with Type 2 Diabetes.
Becht FS; Walther K; Martin E; Nauck MA
Exp Clin Endocrinol Diabetes; 2016 Mar; 124(3):148-56. PubMed ID: 26824281
[TBL] [Abstract][Full Text] [Related]
20. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.
Bogardus C; Lillioja S; Howard BV; Reaven G; Mott D
J Clin Invest; 1984 Oct; 74(4):1238-46. PubMed ID: 6384267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
